Gina Consylman
CIK 1546358 · Chief Financial Officer · last filed 2026-06-05
Gina Consylman is a Chief Financial Officer who has filed 49 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for ASMB, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$772.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions. 30 SEC filings were submitted jointly with IRONWOOD PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IRWD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TWO TOWER PLACE, 7TH FLOOR
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASMB | Director | — | $20.30 | — | $0 | 7 | 2026-06-05 |
| bluebird bio, Inc. (BLUE) Delisted | Chief Financial Officer | 6,269 | $4.97 | $31.2K | $0 | 2 | 2022-02-03 |
| VSTM | Director | — | $10.06 | — | $0 | 4 | 2021-06-30 |
| IRWD | SVP, CFO & Treasurer | 392,616 | $3.55 | $1.39M | -$645.7K | 29 | 2021-03-30 |
| ANALOGIC CORP (ALOG) Delisted | VP-Controller | 775 | — | — | -$126.6K | 7 | 2014-03-07 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2022-02-03 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2021-11-16 | bluebird bio, Inc. (BLUE) Delisted | Other (J) | +100,385 | $0 | EDGAR |
| 2021-06-30 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2021-05-24 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | IRWD | Grant (A) | +56,372 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.